Judge may report drug company executive to attorney general
BMJ 2004; 328 doi: https://doi.org/10.1136/bmj.328.7434.243 (Published 29 January 2004) Cite this as: BMJ 2004;328:243
- Clare Dyer, legal correspondent
- BMJ
A high court judge is considering reporting a senior executive of GlaxoSmithKline to the attorney general after he told an expert witness appearing for the company's opponents in a patent action that the company would not fund any research by him in the future.
Mr Justice Pumfrey, who was last week hearing a patent action brought against Glaxo by a group of generic drug companies over Seretide, its combined inhaler of salmeterol and fluticasone, called Dr Garth Rapeport before him for questioning.
The judge acted after Professor Clive Page, an asthma expert from King's College, London, who was appearing as a witness …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.